Bioactivity of an antihypertensive peptide expressed in Chlamydomonas reinhardtii

Journal of Biotechnology

Volumn 240, Issue , 2016, Pages 76-84

  Ochoa Méndez, Celma Estefanía ^a   Lara Hernández, Ignacio ^a   González, Luzmila Martínez ^a   Aguirre Bañuelos, Patricia ^a   Ibarra Barajas, Maximiliano ^b   Castro Moreno, Patricia ^b   González Ortega, Omar ^a   Soria Guerra, Ruth Elena ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Bioactive peptides; Hypertension; Microalgae; Spontaneous hypertensive rats

Indexed keywords

ALGAE; BLOOD PRESSURE; DIETARY SUPPLEMENTS; PEPTIDES; PROTEINS; RATS; STRAIN;

ANTIHYPERTENSIVE PEPTIDES; BIOACTIVE PEPTIDES; CHLAMYDOMONAS REINHARDTII; GENETICALLY MODIFIED; HYPERTENSION; INTRAGASTRIC ADMINISTRATION; MICRO-ALGAE; SYSTOLIC BLOOD PRESSURE;

RECOMBINANT PROTEINS;

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VALYLLEUCYLPROLYLVALYLPROLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OLIGOPEPTIDE; VALYL-LEUCYL-PROLYL-VALYL-PROLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BIOMASS; CHLAMYDOMONAS REINHARDTII; CONTROLLED STUDY; DIGESTION; DRUG DOSE COMPARISON; ENZYME INHIBITION; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TRANSGENE; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; DRUG EFFECTS; GENETICS; HYPERTENSION; ISOLATION AND PURIFICATION; PATHOPHYSIOLOGY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHLAMYDOMONAS REINHARDTII; HYPERTENSION; MALE; OLIGOPEPTIDES; RATS; RATS, INBRED SHR; RECOMBINANT PROTEINS;

EID: 84993946902     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2016.11.001     Document Type: Article

References (38)

1. Beneteau, B., Baudin, B., Morgant, G., Giboudeau, J., Baumann, F.C., Automated kinetic assay of angiotensin-converting enzyme in serum. Clin. Chem. 32 (1986), 884–886.
2. Campos-Quevedo, N., Rosales-Mendoza, S., Paz-Maldonado, L.M.T., Martínez-Salgado, L., Guevara-Arauza, J.C., Soria-Guerra, R.E., Production of milk-derived bioactive peptides as precursor chimeric proteins in chloroplasts of Chlamydomonas reinhardtii. Plant Cell Tissue Organ Cult. 113 (2013), 217–225.
3. Chan, H.T., Daniell, H., Plant-made vaccines against human infectious diseases. Are we there yet?. Plant Biotechnol. J. 13 (2015), 1056–1070.
4. Cheung, H., Wang, F., Ondetti, M., Sabo, E., Dw, C., Binding of peptide substrates and inhibitors of angiotensinconverting enzyme. Importance of the COOH terminal dipeptide sequence. J. Biol. Chem. 255 (1980), 401–407.
5. Daniell, H., Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol. J. 1 (2006), 1071–1079.
6. Dong, L., Yan, S., Lin, L., Min, L., The absorption mechanism of the antihypertensive peptide, Val-Leu-Pro-Pro-Val (VLPVP), was investigated in the Caco-2 cell model. Acta Nutr. Sin. 4 (2008), 354–358.
7. Fitzgerald, R.J., Meisel, H., Milk protein hydrolysates and bioactive peptides. Fox, P.F., Sweeney, M.C.P.L.H., (eds.) Advanced Dairy Chemistry, 3rd ed., 2003, Kluwer Academic/Plenum Publishers, New York, NY, USA.
8. Fitzgerald, G.F., Murray, B.A., Bioactive peptides and lactic fermentations. Int. J. Dairy Technol. 59 (2006), 118–125.
9. Goldschmidt-Clermont, M., Transgenic expression of aminoglycoside adenine transferase in the chloroplast: a selectable marker of site-directed transformation of chlamydomonas. Nucleic Acids Res. 19 (1991), 4083–4089.
10. Hartmann, R., Meisel, H., Food-derived peptides with biological activity: from research to food applications. Curr. Opin. Biotechnol. 18 (2007), 163–169.
11. Hayes, M., Ross, R.P., Fitzgerald, G.F., Stanton, C., Putting microbes to work: diary fermentation, cell factories and bioactive peptides. Part I: overview. Biotechnol. J. 2 (2007), 426–434.
12. Hong, F., Ming, L., Yi, S., Zhanxia, L., Yongquan, W., Chi, L., The antihypertensive effect of peptides: a novel alternative to drugs?. Peptides 29 (2008), 1062–1071.
13. Huang, L., Ma, H., Li, Y., Li, S., Antihypertensive activity of recombinant peptide IYPR expressed in Escherichia coli as inclusion bodies. Protein Expr. Purif. 83 (2012), 15–20.
14. Hur, S.J., Lim, B.O., Decker, E.A., McClements, D.J., In vitro human digestion models for food applications. Food Chem. 125 (2011), 1–12.
15. Iwaniak, A., Minkiewicz, P., Darewicz, M., Food-originating ACE inhibitors, including antihypertensive peptides, as preventive food components in blood pressure reduction. Compr. Rev. Food Sci. Food Saf. 13 (2014), 114–134.
16. Jin, S., Daniell, H., Engineered chloroplast genome just got smarter. Trends Plant Sci. 20 (2015), 622–640.
17. Korhonen, H., Pihlanto, A., Bioactive peptides: new challenges and opportunities for the dairy industry. Aust. J. Dairy Technol. 58 (2003), 129–134.
18. Kwon, K.C., Verma, D., Singh, N.D., Herzog, R., Daniell, H., Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv. Drug Deliv. Rev. 65 (2013), 782–799.
19. Lei, L., Sun, H., Liu, D., Liu, L., Li, S., Transport of Val-Leu-Pro-Val-Pro in human intestinal epithelial (Caco-2) cell monolayers. J. Agric. Food Chem. 56 (2008), 3582–3586.
20. Lopez-Fandiño, R., Otte, J., Van Camp, J., Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int. Dairy J. 16 (2006), 1277–1293.
21. Maeno, M., Yamamoto, N., Takano, T., Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci., 79, 1996, 131621.
22. Matoba, N., Doyama, N., Yamada, Y., Maruyama, N., Utsumi, S., Yoshikawa, M., Design and production of genetically modified soybean protein with anti-hypertensive activity by incorporating potent analogue of ovokinin (2–7). FEBS Lett. 497 (2001), 50–54.
23. Meira, S.M.M., Daroit, D.J., Helfer, V.E., Corrêa, A.P.F., Segalin, J., Carro, S., Brandelli, A., Bioactive peptides in water-soluble extracts of ovine cheeses from Southern Brazil and Uruguay. Food Res. Int. 48 (2012), 322–329.
24. Meisel, H., Multifunctional peptides encrypted in milk proteins. Biofactors 21 (2004), 55–61.
25. Moller, N., Scholz-Ahrens, K., Roos, N., Schresebneir, J., Bioactive peptides and proteins from foods: indication for health effects. Eur. J. Nutr. 47 (2008), 171–182.
26. Onishi, K., Matoba, N., Yamada, Y., Doyama, N., Maruyama, N., Utsumi, S., Yoshikawa, M., Optimal designing of β-conglycinin to genetically incorporate RPLKPW, a potent anti-hypertensive peptide. Peptides 25 (2004), 37–43.
27. Rasala, B.A., Mayfield, S.P., The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics. Bioeng. Bugs 2 (2011), 50–54.
28. Ryan, U.S., Ryan, J.W., Whitaker, C., Chiu, A., Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell 8 (1976), 125–145.
29. Sambrook, J., Russell, D.W., Molecular Cloning: A Laboratory Manual. 2001, CSHL Press.
30. Schötz, F., Bathelt, H., Arnold, C.G., Schimmer, O., The architecture and organization of the Chlamydomonas cell: Results of serial-section electron microscopy and a three-dimensional reconstruction. Protoplasma 75 (1972), 229–254.
31. Shenoy, V., Kwon, K.C., Rathinasabapathy, A., Lin, S., Jin, G., Song, C., Shil, P., Nair, A., Qi, Y., Li, Q., Francis, J., Katovich, M.J., Daniell, H., Raizada, M.K., Oral delivery of angiotensin-converting enzyme 2 and Angiotensin-(1–7) bioencapsulated in plant cells attenuates pulmonary hypertension. Hypertension 64 (2014), 1248–1259.
32. Shil, P.K., Kwon, K.C., Zhu, P., Verma, A., Daniell, H., Li, Q., Oral delivery of ACE2/Ang-(1–7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis. Mol. Ther. 22 (2014), 2069–2082.
33. Silva, S.V., Malcata, F.X., Caseins as source of bioactive peptides. Int. Dairy J. 15 (2005), 1–15.
34. A global brief on hypertension [WWW Document], n.d. URL http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/ (Accessed 14 April 2016).
35. Wang, X.L., Ma, S.-N., Yuan, Y.-H., Ding, Y., Li, D.-S., Expression and purification recombinant antihypertensive peptide ameliorates hypertension in rats with spontaneous hypertension. Protein Expr. Purif. 113 (2015), 30–34.
36. Xiao, Y., Kwon, K.C., Hoffman, B.E., Kamesh, A., Jones, N.T., Herzog, R.W., Daniell, H., Low cost delivery of proteins bioencapsulated in plantcells to human nonimmune or immune modulatorycells. Biomaterials 80 (2016), 68–79.
37. Yamamoto, N., Masahiro, E., Seiichi, M., Biogenic peptides and their potential use. Curr. Pharm. Des. 9 (2003), 1345–1355.
38. Yang, L., Tada, Y., Yamamoto, M.P., Zhao, H., Yoshikawa, M., Takaiwa, F., A transgenic rice seed accumulating an anti-hypertensive peptide reduces the blood pressure of spontaneously hypertensive rats. FEBS Lett. 580 (2006), 3315–3320.